Improves overall performance
How GLP-1 Medications Achieve Weight Loss Without Stimulants GLP-1 receptor agonists like semaglutide and tirzepatide produce weight loss through appetite suppression, delayed gastric emptying, and improved satiety signalingmechanisms that don't rely on stimulating your nervous system
Zepbound (tirzepatide), FDA-approved for weight management Trulicity (dulaglutide), Saxenda (liraglutide), Victoza (liraglutide) Oral Options: Wegovy pill (semaglutide) FDA-approved for weight loss
& Ryan, C
It reduces blood volume, forcing your heart to work harder to pump oxygen and nutrients to your muscles and brain
In individuals with advanced -cell dysfunction, supplementing insulin therapy with pramlintide, the first and currently only approved injectable short-acting selective analog of amylin, has demonstrated efficacy in enhancing both postprandial and overall glycemic control in both type 2 diabetes (T2D) and type 1 diabetes (T1D) without increasing the risk of hypoglycemia or weight gain